WHO: Hydroxychloroquine Coronavirus trials to resume
The use of Hydroxychloroquine drug in the treatment of the coronavirus has turned crucial. At a press briefing on Wednesday, World Health Organization Director-General Tedros Adhanom Ghebreyesus said an international trial using Hydroxychloroquine to treat the coronavirus patients would be resumed. He said the decision was taken after the 'Data Safety and Monitoring Committee' reviewed the trial data. The U.N. agency paused the treatments against COVID-19 last month over the fear of increased death rates and irregular heartbeats.
Reports suggest that COVID-19 has affected almost 3 million people in the Americas and more than 6.43 million worldwide.